Madison, Wis. - A California-based life sciences company with 120 Madison employees is bolstering its research toolbox to handle the most studied class of proteins in today's drug development market.

The new capability will be made possible by Invitrogen Corp.'s recent acquisition of Sentigen Holding Corp., which will be integrated with Invi......

Full article >>> cells that allow researchers to view cells in a state in which they do not divide.

The acquisition

The deal will allow Carlsbad-based Invitrogen to acquire Phillipsburg, N.J.-based Sentigen's two subsidiaries, Sentigen Biosciences, Inc. and Cell and Molecular Technologies, Inc., subject to approv......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 09/05/06


Related biology technology :

1. Prodesse joins forces with Invitrogen
2. Invitrogen to buy Norwegian biotech with operations in Brown Deer
3. Portal to e-records boosts care at Childrens Hospital
4. Federal grant boosts Medical College research
5. Third Wave boosts numbers in latest report
6. Small Tree boosts bandwidth for Apple G4 and G5 servers
7. The development of a CXCR2 chemokine receptorbinding assay using the LEADseeker Multimodality Imaging System
8. The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System
9. The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System
10. The development of a calcitonin-gene related peptide (CGRP) receptor-binding assay using the LEADseeker Multimodality Imaging System
11. The development of a somatostatin sst4 receptor-binding assay using the LEADseeker Multimodality Imaging System